Journal of Endocrinological Investigation

, Volume 14, Issue 10, pp 853–860

Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves’ ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study

  • Claudio Marcocci
  • L. Bartalena
  • F. Bogazzi
  • G. Bruno-Bossio
  • A. Lepri
  • A. Pinchera


We have carried out a prospective study to investigate whether orbital radiotherapy combined with high dose systemic glucocorticoids is more effective than orbital radiotherapy alone for Graves’ ophthalmopathy. Thirty consecutive patients with relevant and active Graves’ ophthalmopathy were randomly assigned to treatment either with orbital radiotherapy combined with systemic glucocorticoids (Group 1, n =15) or with orbital radiotherapy alone (Group 2, n = 15). The final evaluation was made 6–9 months after beginning treatment. Two patients in each group were lost to follow-up. Ocular involvement and response to treatment were evaluated by the ophthalmopathy index and by clinical assessment. Mean ophthalmopathy index values were 5.85 in Group 1 and 5.46 in Group 2 (p = NS) before treatment, and 2.46 in Group 1 and 3.61 in Group 2 after treatment (p = 0.0001 and p = 0.003 vs initial value, respectively). The mean ophthalmopathy index decrease in Group 1 (−3.39) was significantly greater (p = 0.043) than that in Group 2 (−1.85). Favorable responses on clinical ground occurred in 9 patients (69%) in Group 1 and in 5 patients (38%) in Group 2. The difference was particularly evident on soft tissue changes and extraocular muscle involvement. Severe eye muscle restriction was substantially unaffected by either treatment. In conclusion, the association of orbital irradiation and high dose systemic glucocorticoids in the treatment of severe Graves’ ophthalmopathy provides more favorable responses than orbital radiotherapy alone.


Graves’ ophthalmopathy orbital radiotherapy systemic glucocorticoids Graves’ disease exophthalmos 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jacobson D.H., Gorman C.A. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr. Rev. 5: 200, 1984.PubMedCrossRefGoogle Scholar
  2. 2.
    McConahey W.M. Medical therapy. In: Gorman C.A., Waller R.R., Dyer J.A., (Eds.), The eye and orbit in Graves’ disease. Raven Press New York: 1984, p. 317.Google Scholar
  3. 3.
    Pinchera A., Bartalena L., Chiovato L., Marcocci C. Radiotherapy of Graves’ ophthalmopathy. In: Gorman C.A., Waller R.R., Dyer J.A., (Eds.), The eye and orbit in Graves’ disease. Raven Press New York: 1984, p. 301.Google Scholar
  4. 4.
    Pinchera A., Bartalena L., Marcocci C., Ceccarelli P., Cucchi P., Vitti P., Mariotti S., Fenzi G.F. Humoral autoimmunity in endocrine ophthalmopathy. Acta Endocrinol. (Copenh) 121(Suppl. 2): 112, 1989.Google Scholar
  5. 5.
    Kriss J.P. Pathogenesis and treatment of Graves’ ophthalmopathy. Thyroid Today 7: 1, 1984.Google Scholar
  6. 6.
    Bartalena L., Marcocci C., Chiovato L., Laddaga M., Lepri G., Andreani D., Cavallacci G., Baschieri L., Pinchera A. Orbital cobalt irradiation combined with systemic corticosteroids for Graves’ ophthalmopathy: comparison with systemic corticosteroids alone. J. Clin. Endocrinol. Metab. 56: 1139, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Kriss J.P., Petersen I.A., Donaldson S.S., McDougall I.R. Supervoltage orbital radiotherapy for progressive Graves’ ophthalmopathy: results of a twenty-year experience. Acta Endocrinol. (Copenh.) 121(Suppl 2): 154, 1989.Google Scholar
  8. 8.
    Werner S.C. Modification of the classification of the eye changes of Graves’ disease: recommendations of the ad hoc Committee of the American Thyroid Association. J. Clin. Endocrinol. Metab. 44: 203, 1977.PubMedCrossRefGoogle Scholar
  9. 9.
    Donaldson S.S., Bagshaw M.A., Kriss J.P. Supervoltage orbital radiotherapy for Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 37: 276, 1983.CrossRefGoogle Scholar
  10. 10.
    Marcocci C., Bartalena L., Panicucci M., Marconcini C., Cartei F., Cavallacci G., Laddaga M., Campobasso G., Baschieri L., Pinchera A. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves’ ophthalmopathy: a comparative study. Clin. Endocrinol. (Oxf.) 27: 33, 1987.CrossRefGoogle Scholar
  11. 11.
    Mourits M., Koornneef L., Wiersinga W.M., Prummel M.F., Berghout A., van der Gaag R. Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach. Br. J. Ophthalmol. 73: 639, 1989.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Brown J., Coburn J.W., Wigod R.A., Hiss J.M., Dowling J.T. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves’ disease. Am. J. Med. 34: 786, 1963.PubMedCrossRefGoogle Scholar
  13. 13.
    Werner S.C. Prednisone in emergency treatment of malignant exophthalmos. Lancet 1: 1004, 1966.CrossRefGoogle Scholar
  14. 14.
    Kahaly G., Schrezenmeir J., Krause U. Ciclosporin and prednisone v. prednisone in the treatment of Graves’ ophthalmopathy: a controlled, randomized and prospective study. Eur. J. Clin. Invest. 16: 415–22, 1986.PubMedCrossRefGoogle Scholar
  15. 15.
    Covington E.E., Lobes L., Sudarsanam A. Radiation therapy of exophthalmos: report of seven cases. Radiology 122: 797, 1976.Google Scholar
  16. 16.
    Olivotto A., Ludgate C.M., Allen L.H., Rootman J. Supervoltage radiotherapy for Graves’ ophthalmopathy: CCABC technique and results. Int. J. Radiat. Oncol. Biol. Phys. 11: 2085, 1985.PubMedCrossRefGoogle Scholar
  17. 17.
    Bartalena L., Marcocci C., Bogazzi F., Panicucci M., Lepri A., Pinchera A. Use of corticosteroids to prevent progression of Graves’ ophthalmopathy after radioiodine therapy for hyperthyroidism. N. Engl. J. Med. 321: 1349, 1989.PubMedCrossRefGoogle Scholar
  18. 18.
    Bartalena L., Marcocci C., Bogazzi F., Bruno-Bossio G., Pinchera A. Glucocorticoid therapy of Graves’ ophthalmopathy. Exp. Clin. Endocrinol. 97: 320, 1991.PubMedCrossRefGoogle Scholar
  19. 19.
    Marcocci C., Bartalena L., Bogazzi F., Bruno-Bossio G., Pinchera A. Role of orbital radio therapy in the treatment of Graves’ opthalmopathy. Exp. Clin. Endocrinol. 97: 332, 1991.PubMedCrossRefGoogle Scholar
  20. 20.
    Bartalena L., Marcocci C., Bogazzi F. A new ophthalmopathy index for quantitation of eye changes of Graves’ disease. Acta Endocrinol. (Copenh.) 121(Suppl 2): 190, 1989.Google Scholar
  21. 21.
    Bahn R.S., Garrity J.A., Bartley G.B., Gorman C.A. Diagnostic evaluation of Graves’ ophthalmopathy. Endocrinol. Metab. Clin. North. Am. 17: 527, 1988.PubMedGoogle Scholar
  22. 22.
    Brennan M.W., Leone C.R., Janaki L. Radiation therapy for Graves’ disease. Am. J. Ophtalmol. 96: 195, 1983.Google Scholar
  23. 23.
    Utiger R.D. Treatment of Graves’ ophthalmopathy. N. Engl. J. Med. 321: 1403, 1989.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1991

Authors and Affiliations

  • Claudio Marcocci
    • 1
  • L. Bartalena
    • 1
  • F. Bogazzi
  • G. Bruno-Bossio
    • 1
  • A. Lepri
    • 2
  • A. Pinchera
    • 1
  1. 1.Istituto di EndocrinologiaUniversita di PisaTirrenia-PisaItaly
  2. 2.Clinica OculisticaUniversità di PisaPisaItaly

Personalised recommendations